Home > Insider Trading > Filing (0001181431-13-063459)

Filing Details

Accession Number:: 0001181431-13-063459
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-18 19:00:09
Reporting Period:: 2013-12-16

Filing Date:: 2013-12-18
Accepted Time:: 2013-12-18 19:00:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1392380	Gevo Inc.	GEVO	Industrial Organic Chemicals (2860)	870747704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478381	Shai Weiss	C/O Vgf Advisers (Us) Llc 27 South Park Street, Suite 200 San Francisco CA 94107		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-16	18,519	$0.00	18,519	No	4	P	Direct
Common Stock	Acquisiton	2013-12-16	370,370	$0.00	3,124,288	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right-to-buy)	Acquisiton	2013-12-16	18,519	$0.00	18,519	$1.85
Common Stock	Common Stock Warrants (right-to-buy)	Acquisiton	2013-12-16	370,370	$0.00	370,370	$1.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,519	2013-12-16	2018-12-16	No	4	P	Direct
100,000	2013-12-16	2018-12-16	No	4	P	Indirect

Footnotes

The shares of common stock and the warrants to purchase common stock were purchased together as common stock units, but were issued separately. Each common stock unit consisted of one share of common stock and a warrant to purchase one share of common stock, at a public offering price of $1.35 per common stock unit. Each warrant has an exercise price of $1.85 per share (subject to adjustment in certain circumstances), became exercisable on the date of original issuance and will expire on December 16, 2018.
Mr. Weiss purchased 18,519 shares of Gevo common stock and warrants to purchase 18,519 shares of common stock on December 16, 2013 and owns such shares and warrants directly. The additional securities reported as indirectly owned by Mr. Weiss reflect securities owned directly by Virgin Green Fund I, L.P. (the "Fund"). VGF Partners I, L.P. is the general partner (the "Direct General Partner") of the Fund and may be deemed to have the sole voting and dispositive power over the securities held by the Fund. VGF I Limited is the general partner of the Direct General Partner (the "Ultimate General Partner") and may be deemed to have the sole voting and dispositive power over the securities held by the Fund. Mr. Weiss is a director of the Ultimate General Partner and may be deemed to share in the voting and dispositive power over the securities held by the Fund. Mr. Weiss disclaims beneficial ownership of the securities held by the Fund except to the extent of any pecuniary interest therein.
The number of securities beneficially owned following the reported transaction have been estimated based on the 4.999% ownership limitation contained in the warrants. Under the terms of the warrants, during any period of time in which a holder's beneficial ownership of Gevo's common stock is less than 5%, any exercise notice with respect to the warrants delivered by such holder will be deemed automatically not to have been so delivered by such holder to the extent, but only to the extent, that delivery of shares of Gevo's common stock otherwise deliverable upon such exercise would result in such holder having a beneficial ownership of Gevo's common stock in excess of 4.999%. A holder may only increase the 4.999% ownership limitation upon 65 days prior written notice to Gevo.